Padda SK, Reckamp KL, Koczywas M, Neal JW, et al. A phase 1b study of erlotinib and momelotinib for the treatment of EGFR-mutated, tyrosine kinase inhibitor-naive metastatic non-small cell lung cancer. Cancer Chemother Pharmacol 2021 Nov 13. pii: 10.1007/s00280-021-04369.
PMID: 34773474